COMPOSITIONS INCLUDING FATP1, FATP3, FATP4, FATP5, AND/OR FATP6 INHIBITORS AND USES THEREOF

摘要

The present disclosure relates generally to methods for ameliorating or treating melanoma. In particular, the present technology relates to administering a therapeutically effective amount of one or more compositions that inhibit the FATP1, FATP3, FATP4, FATP5, and/or FATP6 transporter protein to a subject diagnosed with, or at risk for melanoma.